BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35653587)

  • 1. Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia.
    Song H; Liu Y; Tan Y; Zhang Y; Jin W; Chen L; Wu S; Yan J; Li J; Chen Z; Chen S; Wang K
    Blood; 2022 Sep; 140(10):1132-1144. PubMed ID: 35653587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia.
    Gaur GC; Ramadan SM; Cicconi L; Noguera NI; Luna I; Such E; Lavorgna S; Di Giandomenico J; Sanz MA; Lo-Coco F
    Ann Hematol; 2012 Dec; 91(12):1855-60. PubMed ID: 22895555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative approach reveals genetic complexity and epigenetic perturbation in acute promyelocytic leukemia: a single institution experience.
    Rahimi N; Zhang Y; Mina A; Altman JK; Sukhanova M; Frankfurt O; Jennings L; Lu X; Behdad A; Chen Q; Chen YH; Gao J
    Hum Pathol; 2019 Sep; 91():1-10. PubMed ID: 31125631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In APL, noncoding mutations and SNP converge on WT1.
    Wu HC; de Thé H
    Blood; 2022 Sep; 140(10):1060-1061. PubMed ID: 36074531
    [No Abstract]   [Full Text] [Related]  

  • 6. WT1 regulates cyclin A1 expression in K562 cells.
    Pandey S; Moazam M; Ghimirey N; Kuerbitz SJ; Fraizer GC
    Oncol Rep; 2019 Nov; 42(5):2016-2028. PubMed ID: 31436300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.
    Madan V; Shyamsunder P; Han L; Mayakonda A; Nagata Y; Sundaresan J; Kanojia D; Yoshida K; Ganesan S; Hattori N; Fulton N; Tan KT; Alpermann T; Kuo MC; Rostami S; Matthews J; Sanada M; Liu LZ; Shiraishi Y; Miyano S; Chendamarai E; Hou HA; Malnassy G; Ma T; Garg M; Ding LW; Sun QY; Chien W; Ikezoe T; Lill M; Biondi A; Larson RA; Powell BL; Lübbert M; Chng WJ; Tien HF; Heuser M; Ganser A; Koren-Michowitz M; Kornblau SM; Kantarjian HM; Nowak D; Hofmann WK; Yang H; Stock W; Ghavamzadeh A; Alimoghaddam K; Haferlach T; Ogawa S; Shih LY; Mathews V; Koeffler HP
    Leukemia; 2016 Aug; 30(8):1672-81. PubMed ID: 27063598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
    Yoon JH; Kim HJ; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    J Hematol Oncol; 2017 Jan; 10(1):30. PubMed ID: 28114959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy.
    Valiulienė G; Treigytė G; Savickienė J; Matuzevičius D; Alksnė M; Jarašienė-Burinskaja R; Bukelskienė V; Navakauskas D; Navakauskienė R
    Biomed Pharmacother; 2016 Apr; 79():62-70. PubMed ID: 27044813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor function of Gata2 in acute promyelocytic leukemia.
    Katerndahl CDS; Rogers ORS; Day RB; Cai MA; Rooney TP; Helton NM; Hoock M; Ramakrishnan SM; Nonavinkere Srivatsan S; Wartman LD; Miller CA; Ley TJ
    Blood; 2021 Sep; 138(13):1148-1161. PubMed ID: 34125173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of expression of the Wilms' tumor 1 gene in newly diagnosed acute promyelocytic leukemia.
    Hecht A; Nolte F; Nowak D; Nowak V; Reinwald M; Hanfstein B; Faldum A; Büchner T; Spiekermann K; Sauerland C; Weiss C; Hofmann WK; Lengfelder E
    Leuk Lymphoma; 2015; 56(8):2289-95. PubMed ID: 25426668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FLT3 mutation in acute promyelocytic leukemia patients with extramedullary relapse].
    Liu J; Zou XL; Liu TT; Jiang M; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):670-4. PubMed ID: 25286697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression.
    Wartman LD; Larson DE; Xiang Z; Ding L; Chen K; Lin L; Cahan P; Klco JM; Welch JS; Li C; Payton JE; Uy GL; Varghese N; Ries RE; Hoock M; Koboldt DC; McLellan MD; Schmidt H; Fulton RS; Abbott RM; Cook L; McGrath SD; Fan X; Dukes AF; Vickery T; Kalicki J; Lamprecht TL; Graubert TA; Tomasson MH; Mardis ER; Wilson RK; Ley TJ
    J Clin Invest; 2011 Apr; 121(4):1445-55. PubMed ID: 21436584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute WT1-positive promyelocytic leukemia with hypogranular variant morphology, bcr-3 isoform of PML-RARα and Flt3-ITD mutation: a rare case report.
    Zhang X; Yang C; Peng X; Chen X; Feng Y
    Sao Paulo Med J; 2017; 135(2):179-184. PubMed ID: 28125133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
    Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia.
    Qian M; Jin W; Zhu X; Jia X; Yang X; Du Y; Wang K; Zhang J
    J Hematol Oncol; 2013 Apr; 6():25. PubMed ID: 23547873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of Wilms' tumor 1 gene expression level on prognosis and risk stratification of acute promyelocytic leukemia patients.
    Mitrovic M; Kostic T; Virijevic M; Karan-Djurasevic T; Suvajdzic Vukovic N; Pavlovic S; Tosic N
    Int J Lab Hematol; 2020 Feb; 42(1):82-87. PubMed ID: 31830382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations.
    Ibáñez M; Carbonell-Caballero J; García-Alonso L; Such E; Jiménez-Almazán J; Vidal E; Barragán E; López-Pavía M; LLop M; Martín I; Gómez-Seguí I; Montesinos P; Sanz MA; Dopazo J; Cervera J
    PLoS One; 2016; 11(2):e0148346. PubMed ID: 26886259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic efficacy of WT1 expression in asymptomatic acute promyelocytic leukemia].
    Eda H; Watanabe S; Ogasawara F; Saeki K; Yoshida S; Togitani K; Takeuchi A; Miyazaki S; Kojima K
    Rinsho Ketsueki; 2022; 63(11):1520-1524. PubMed ID: 36476791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia with Flt3-TKD and WT1 mutations relapsing in a testicle and followed by systemic relapse.
    Zou XL; Zeng K; Xie LP; Wang L; Chen M; Liu T; Niu T
    Acta Haematol; 2013; 130(4):223-9. PubMed ID: 23816818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.